Experience of a Single Center in NTBC Use in Management of Hereditary Tyrosinemia Type I in Libya

BACKGROUND: Hereditary Tyrosinemia type I (HTI) is a metabolic disease caused by deficiency of fumarylacetoacetate hydrolase enzyme. OBJECTIVES: This study reports beside its clinical and biochemical presentation, the outcome of NTBC [2- (2-nitro-4-trifloro-methylbenzoyl)-1, 3-cyclohexanedion] treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Alobaidy, Hanna, Barkaoui, Emna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610339/
https://www.ncbi.nlm.nih.gov/pubmed/26495099
http://dx.doi.org/10.5812/ijp.3608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610339/
https://www.ncbi.nlm.nih.gov/pubmed/26495099
http://dx.doi.org/10.5812/ijp.3608

Ejemplares similares